Works matching AU Calvo, Emiliano

Results: 65
    1
    2

    Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103).

    Published in:
    Journal of Clinical Pharmacology, 2024, v. 64, n. 5, p. 544, doi. 10.1002/jcph.2397
    By:
    • Garralda, Elena;
    • Oh, Do Youn;
    • Italiano, Antoine;
    • Bedard, Philippe L.;
    • Delord, Jean‐Pierre;
    • Calvo, Emiliano;
    • LoRusso, Patricia;
    • Wainberg, Zev;
    • Cervantes, Andres;
    • Rodriguez‐Vida, Alejo;
    • Shemesh, Colby S.;
    • Sane, Rucha;
    • Mendus, Diana;
    • Ding, Hao;
    • Hendricks, Robert;
    • Meng, Ray;
    • Cho, Byoung Chul;
    • Kim, Tae Won;
    • Wu, Benjamin
    Publication type:
    Article
    3
    4
    5

    Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03790-7
    By:
    • Geva, Ravit;
    • Vieito, Maria;
    • Ramon, Jorge;
    • Perets, Ruth;
    • Pedregal, Manuel;
    • Corral, Elena;
    • Doger, Bernard;
    • Calvo, Emiliano;
    • Bardina, Jorge;
    • Garralda, Elena;
    • Brown, Regina J.;
    • Greger, James G.;
    • Wu, Shujian;
    • Steinbach, Douglas;
    • Yao, Tsun-Wen Sheena;
    • Cao, Yu;
    • Lauring, Josh;
    • Chaudhary, Ruchi;
    • Patel, Jaymala;
    • Patel, Bharvin
    Publication type:
    Article
    6

    First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 417, doi. 10.1007/s00262-021-02973-w
    By:
    • Italiano, Antoine;
    • Cassier, Philippe A.;
    • Lin, Chia-Chi;
    • Alanko, Tuomo;
    • Peltola, Katriina J.;
    • Gazzah, Anas;
    • Shiah, Her-Shyong;
    • Calvo, Emiliano;
    • Cervantes, Andrés;
    • Roda, Desamparados;
    • Tosi, Diego;
    • Gao, Bo;
    • Millward, Michael;
    • Warburton, Lydia;
    • Tanner, Minna;
    • Englert, Stefan;
    • Lambert, Stacie;
    • Parikh, Apurvasena;
    • Afar, Daniel E.;
    • Vosganian, Gregory
    Publication type:
    Article
    7

    Mapping MAGE-A4 expression in solid cancers for targeted therapies.

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1484182
    By:
    • Habigt, Christin;
    • Rottey, Sylvie;
    • Spanggaard, Iben;
    • Lopez, Juanita S.;
    • Garralda, Elena;
    • Calvo, Emiliano;
    • Bechter, Oliver;
    • Desai, Jayesh;
    • Galot, Rachel;
    • Gandhi, Leena;
    • Heil, Florian;
    • Rieder, Natascha;
    • Dimitrov, Ivan;
    • Quetglas, Iris Martinez;
    • Heichinger, Christian;
    • Keshelava, Nino;
    • Roller, Andreas
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first‐line metastatic renal carcinoma (SUNRISES study).

    Published in:
    BJU International, 2020, v. 126, n. 5, p. 559, doi. 10.1111/bju.15165
    By:
    • Rodriguez‐Vida, Alejo;
    • Bamias, Aristotelis;
    • Esteban, Emilio;
    • Saez, Maria Isabel;
    • Lopez‐Brea, Marta;
    • Castellano, Daniel;
    • Caballero, Cristina;
    • Gonzalez‐Larriba, Jose Luis;
    • Calvo, Emiliano;
    • Macia, Sonia;
    • Ravaud, Alain;
    • Bellmunt, Joaquim
    Publication type:
    Article
    14

    A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors.

    Published in:
    Science Translational Medicine, 2023, v. 15, n. 695, p. 1, doi. 10.1126/scitranslmed.abp9229
    By:
    • Melero, Ignacio;
    • Tanos, Tamara;
    • Bustamante, Mariana;
    • Sanmamed, Miguel F.;
    • Calvo, Emiliano;
    • Moreno, Irene;
    • Moreno, Victor;
    • Hernandez, Tatiana;
    • Martinez Garcia, Maria;
    • Rodriguez-Vida, Alejo;
    • Tabernero, Josep;
    • Azaro, Analia;
    • Ponz-Sarvisé, Mariano;
    • Spanggaard, Iben;
    • Rohrberg, Kristoffer;
    • Guarin, Ernesto;
    • Nüesch, Eveline;
    • Davydov, Iakov I.;
    • Ooi, Chiahuey;
    • Duarte, José
    Publication type:
    Article
    15
    16

    Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.

    Published in:
    2000
    By:
    • Rodriguez, Javier;
    • Cortes, Javier;
    • Calvo, Emiliano;
    • Azinovic, Ignacio;
    • Fernandez-Hildago, Oscar;
    • Martinez-Monge, Rafael;
    • Garzon, Carlos;
    • de Irala, Jokin;
    • Martinez-Aguillo, Maite;
    • Ramon y Cajal, Teresa;
    • Brugarolas, Antonio;
    • Rodriguez, J;
    • Cortes, J;
    • Calvo, E;
    • Azinovic, I;
    • Fernandez-Hildago, O;
    • Martinez-Monge, R;
    • Garzon, C;
    • de Irala, J;
    • Martinez-Aguillo, M
    Publication type:
    journal article
    17

    Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2010, v. 182, n. 3, p. 396, doi. 10.1164/rccm.200911-1720OC
    By:
    • White, Dorothy A.;
    • Camus, Philippe;
    • Endo, Masahiro;
    • Escudier, Bernard;
    • Calvo, Emiliano;
    • Akaza, Hideyuki;
    • Uemura, Hirotsugu;
    • Kpamegan, Euloge;
    • Kay, Andrea;
    • Robson, Matthew;
    • Ravaud, Alain;
    • Motzer, Robert J.
    Publication type:
    Article
    18
    19

    Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x
    By:
    • Chia-Chi Lin;
    • Calvo, Emiliano;
    • Papadopoulos, Kyriakos P.;
    • Patnaik, Amita;
    • Sarantopoulos, John;
    • Mita, Alain C.;
    • Preston, Glenn G.;
    • Mita, Monica M.;
    • Rodon, Jordi;
    • Mays, Theresa;
    • I.-Tien Yeh;
    • O'Rourke, Pat;
    • Takimoto, Chris H.;
    • Dancey, Janet E.;
    • Chen, Helen;
    • Tolcher, Anthony W.
    Publication type:
    Article
    20
    21

    The future of oncology therapeutics.

    Published in:
    2017
    By:
    • Mansinho, André;
    • Boni, Valentina;
    • de Miguel, María;
    • Calvo, Emiliano;
    • Mansinho, André;
    • de Miguel, María
    Publication type:
    Editorial
    22
    23
    24

    Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.

    Published in:
    Cancers, 2020, v. 12, n. 10, p. 2985, doi. 10.3390/cancers12102985
    By:
    • Chau, Ian;
    • Penel, Nicolas;
    • Soriano, Andres O.;
    • Arkenau, Hendrik-Tobias;
    • Cultrera, Jennifer;
    • Santana-Davila, Rafael;
    • Calvo, Emiliano;
    • Le Tourneau, Christophe;
    • Zender, Lars;
    • Bendell, Johanna C.;
    • Mi, Gu;
    • Gao, Ling;
    • McNeely, Samuel Clark;
    • Oliveira, Joana M.;
    • Ferry, David;
    • Herbst, Roy S.;
    • Fuchs, Charles S.
    Publication type:
    Article
    25
    26
    27
    28

    Barriers to publishing early phase clinical trials: the oncologists' perspective.

    Published in:
    Oncologist, 2025, v. 30, n. 4, p. 1, doi. 10.1093/oncolo/oyaf042
    By:
    • Lucassen, Merel J J;
    • Bergmann, Pedro;
    • Husson, Olga;
    • Banerji, Udai;
    • Basu, Bristi;
    • Melero, Ignacio;
    • Calvo, Emiliano;
    • Cassier, Philippe A;
    • Drilon, Alexander;
    • Fong, Peter C;
    • Garralda, Elena;
    • Joshua, Anthony M;
    • Lin, Chia-Chi;
    • Lopez, Juanita;
    • Moreno, Victor;
    • Minchom, Anna;
    • Plummer, Ruth;
    • Postel-Vinay, Sophie;
    • Spreafico, Anna;
    • Shimizu, Toshio
    Publication type:
    Article
    29
    30

    Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

    Published in:
    Oncologist, 2021, v. 26, n. 9, p. e1508, doi. 10.1002/onco.13810
    By:
    • Babiker, Hani;
    • Brana, Irene;
    • Mahadevan, Daruka;
    • Owonikoko, Taofeek;
    • Calvo, Emiliano;
    • Rischin, Danny;
    • Moreno, Victor;
    • Papadopoulos, Kyriakos P.;
    • Crittenden, Marka;
    • Formenti, Silvia;
    • Giralt, Jordi;
    • Garrido, Pilar;
    • Soria, Ainara;
    • Hervás‐Morón, Asunción;
    • Mohan, Kosalai Kal;
    • Fury, Matthew;
    • Lowy, Israel;
    • Mathias, Melissa;
    • Feng, Minjie;
    • Li, Jingjin
    Publication type:
    Article
    31
    32
    33

    Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 13, p. 1, doi. 10.1002/cam4.7385
    By:
    • Stradella, Agostina;
    • Johnson, Melissa;
    • Goel, Sanjay;
    • Park, Haeseong;
    • Lakhani, Nehal;
    • Arkenau, Hendrik‐Tobias;
    • Galsky, Matthew D.;
    • Calvo, Emiliano;
    • Baz, Vicente;
    • Moreno, Victor;
    • Saavedra, Omar;
    • Luen, Stephen J.;
    • Mu, Song;
    • Wan, Qiting;
    • Chang, Victoria;
    • Zhang, Wa;
    • Barve, Minal
    Publication type:
    Article
    34
    35

    Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug–Drug Interaction Study.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 182, doi. 10.3390/ph17020182
    By:
    • Moreno, Irene;
    • Hernández, Tatiana;
    • Calvo, Emiliano;
    • Fudio, Salvador;
    • Kahatt, Carmen;
    • Fernández, Cristian;
    • Iglesias, Jorge Luis;
    • Corral, Gema;
    • Pérez-Ramos, Laura;
    • Montilla, Lola;
    • Zeaiter, Ali;
    • Lubomirov, Rubin
    Publication type:
    Article
    36
    37
    38
    39

    Understanding the Preclinical Efficacy of Antibody–Drug Conjugates.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 23, p. 12875, doi. 10.3390/ijms252312875
    By:
    • Díaz-Tejeiro, Cristina;
    • López de Sá, Alfonso;
    • Poyatos-Racionero, Elisa;
    • Ballestín, Pablo;
    • Bartolomé, Jorge;
    • Calvo, Emiliano;
    • Moreno, Víctor;
    • Moris, Francisco;
    • Pérez-Segura, Pedro;
    • Gyorffy, Balazs;
    • Pandiella, Atanasio;
    • Ocaña, Alberto
    Publication type:
    Article
    40

    Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5345, doi. 10.3390/ijms25105345
    By:
    • Sanvicente García, Adrián;
    • Pedregal, Manuel;
    • Paniagua-Herranz, Lucía;
    • Díaz-Tejeiro, Cristina;
    • Nieto-Jiménez, Cristina;
    • Pérez Segura, Pedro;
    • Munkácsy, Gyöngyi;
    • Győrffy, Balázs;
    • Calvo, Emiliano;
    • Moreno, Víctor;
    • Ocaña, Alberto
    Publication type:
    Article
    41
    42

    Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2222, doi. 10.3390/ijms25042222
    By:
    • Paniagua-Herranz, Lucía;
    • Moreno, Irene;
    • Nieto-Jiménez, Cristina;
    • Garcia-Lorenzo, Esther;
    • Díaz-Tejeiro, Cristina;
    • Sanvicente, Adrián;
    • Doger, Bernard;
    • Pedregal, Manuel;
    • Ramón, Jorge;
    • Bartolomé, Jorge;
    • Manzano, Arancha;
    • Gyorffy, Balázs;
    • Gutierrez-Uzquiza, Álvaro;
    • Pérez Segura, Pedro;
    • Calvo, Emiliano;
    • Moreno, Víctor;
    • Ocana, Alberto
    Publication type:
    Article
    43
    44
    45

    Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 4, p. 762, doi. 10.1007/s10637-022-01247-1
    By:
    • LoRusso, Patricia;
    • Ratain, Mark J.;
    • Doi, Toshihiko;
    • Rasco, Drew W.;
    • de Jonge, Maja J. A.;
    • Moreno, Victor;
    • Carneiro, Benedito A.;
    • Devriese, Lot A.;
    • Petrich, Adam;
    • Modi, Dimple;
    • Morgan-Lappe, Susan;
    • Nuthalapati, Silpa;
    • Motwani, Monica;
    • Dunbar, Martin;
    • Glasgow, Jaimee;
    • Medeiros, Bruno C.;
    • Calvo, Emiliano
    Publication type:
    Article
    46
    47

    Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 5, p. 1275, doi. 10.1007/s10637-020-01025-x
    By:
    • Olmedo, María Eugenia;
    • Forster, Martin;
    • Moreno, Victor;
    • López-Criado, María Pilar;
    • Braña, Irene;
    • Flynn, Michael;
    • Doger, Bernard;
    • de Miguel, María;
    • López-Vilariño, José Antonio;
    • Núñez, Rafael;
    • Kahatt, Carmen;
    • Cullell-Young, Martin;
    • Zeaiter, Ali;
    • Calvo, Emiliano
    Publication type:
    Article
    48

    A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 5, p. 1483, doi. 10.1007/s10637-020-00908-3
    By:
    • Cleary, James M.;
    • Calvo, Emiliano;
    • Moreno, Victor;
    • Juric, Dejan;
    • Shapiro, Geoffrey I.;
    • Vanderwal, Carol Ann;
    • Hu, Beibei;
    • Gifford, Maryella;
    • Barch, David;
    • Roberts-Rapp, Lisa;
    • Ansell, Peter J.;
    • Xiong, Hao;
    • Ocampo, Christopher;
    • Tolcher, Anthony W.
    Publication type:
    Article
    49

    Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 3, p. 476, doi. 10.1007/s10637-017-0546-9
    By:
    • Calvo, Emiliano;
    • Azaro, Analia;
    • Rodon, Jordi;
    • Dirix, Luc;
    • Huizing, Manon;
    • Senecal, Francis Mark;
    • LoRusso, Patricia;
    • Yee, Lorrin;
    • Poggesi, Italo;
    • de Jong, Jan;
    • Triantos, Spyros;
    • Park, Youn C.;
    • Knoblauch, Roland E.;
    • Parekh, Trilok V.;
    • Demetri, George D.;
    • von Mehren, Margaret
    Publication type:
    Article
    50